T

Tennessee Retina | Research Department

Research site
(Unclaimed)
Location
345 23rd Avenue North, Suite 350, Nashville, Tennessee, United States of America
Site insights

Top conditions

Macular Degeneration (11 trials)

Geographic Atrophy (6 trials)

Atrophy (5 trials)

Uveitis (2 trials)

Posterior Uveitis (1 trial)

Top treatments

Razuprotafib
IONIS-FB-LRx
Strontium90 Beta
Fluocinolone Acetonide
Adalimumab
ranibizumab
AVD-104
BI 771716
Pegcetacoplan
AKB-9778

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

5 of 15
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment

Enrolling
Neovascular (Wet) Age-Related Macular Degeneration
Biological: Aflibercept IVT
Biological: 4D-150 IVT

Investigate the Safety, Pharmacokinetics, and Treatment effects of Single and Multi-dose of Intravitreal AVD-104 in participants with geographic atro...

Enrolling
Macular Degeneration
Geographic Atrophy of the Macula
Drug: AVD-104
Drug: Avacincaptad

This study is open to adults with geographic atrophy, an advanced form of age-related macular degeneration. People can join the study if they are at...

Active, not recruiting
Geographic Atrophy
Drug: BI 771716

A study to evaluate the safety and efficacy of YUTIQ® 0.18 mg intravitreal implant for the management of chronic non-infectious posterior segment uve...

Enrolling
Uveitis, Posterior
Drug: Fluocinolone Acetonide Intravitreal Implant 0.18 mg

Evaluate the effect of IONIS-FB-LRx on the rate of change of the area of geographic atrophy (GA) secondary to age-related macular degeneration (AMD)...

Active, not recruiting
Macular Degeneration
Geographic Atrophy
Drug: Placebo
Drug: IONIS-FB-LRx

Trial sponsors

4

4D Molecular Therapeutics (4DMT) (1 trial)

Boehringer Ingelheim logo

Boehringer Ingelheim (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems